Cargando…

Pharmacokinetics of Apixaban Among Peritoneal Dialysis Patients

RATIONALE & OBJECTIVE: The efficacy and safety profile of apixaban remains uncertain in patients receiving peritoneal dialysis (PD) despite increasing use in this population. Accordingly, we assessed the pharmacokinetics of apixaban among patients receiving PD. STUDY DESIGN: A pharmacokinetics s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fung, Winston Wing-Shing, Cheng, Phyllis Mei-Shan, Ng, Jack Kit-Chung, Chan, Gordon Chun-Kau, Chow, Kai Ming, Li, Philip Kam-Tao, Szeto, Cheuk Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393585/ https://www.ncbi.nlm.nih.gov/pubmed/37533565 http://dx.doi.org/10.1016/j.xkme.2023.100646

Ejemplares similares

Excessive risk and poor outcome of hospital-acquired peritoneal dialysis-related peritonitis
por: Szeto, Cheuk-Chun, et al.
Publicado: (2022)

Impact of Weight Gain on the Subsequent Survival of New Peritoneal Dialysis Patients
por: Than, Win Hlaing, et al.
Publicado: (2023)

Extended antibiotic therapy for the prevention of relapsing and recurrent peritonitis in peritoneal dialysis patients: a randomized controlled trial
por: Szeto, Cheuk-Chun, et al.
Publicado: (2021)

The change in the prevalence of obesity and new-onset diabetes in Chinese peritoneal dialysis patients over 25 years
por: Than, Win Hlaing, et al.
Publicado: (2021)

Longitudinal Changes of NF-κB Downstream Mediators and Peritoneal Transport Characteristics in Incident Peritoneal Dialysis Patients
por: Fung, Winston Wing-Shing, et al.
Publicado: (2020)

Omentin-1 Levels and Outcomes in Incident Peritoneal Dialysis Patients
por: Than, Win Hlaing, et al.
Publicado: (2023)

Plasma vaspin levels and clinical outcome in incident peritoneal dialysis patients
por: Than, Win Hlaing, et al.
Publicado: (2023)

Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients
por: Than, Win Hlaing, et al.
Publicado: (2022)

The Impact of Volume Overload on the Longitudinal Change of Adipose and Lean Tissue Mass in Incident Chinese Peritoneal Dialysis Patients
por: Ng, Jack Kit-Chung, et al.
Publicado: (2022)

Interaction between central obesity and frailty on the clinical outcome of peritoneal dialysis patients
por: Chan, Gordon Chun-Kau, et al.
Publicado: (2020)

Depression does not predict clinical outcome of Chinese peritoneal Dialysis patients after adjusting for the degree of frailty
por: Chan, Gordon Chun-Kau, et al.
Publicado: (2020)

Asymptomatic fluid overload predicts survival and cardiovascular event in incident Chinese peritoneal dialysis patients
por: Ng, Jack Kit-Chung, et al.
Publicado: (2018)

Urinary and Kidney Podocalyxin and Podocin Levels in Diabetic Kidney Disease: A Kidney Biopsy Study
por: Zeng, Lingfeng, et al.
Publicado: (2022)

Intrarenal and Urinary Glycogen Synthase Kinase-3 Beta Levels in Diabetic and Nondiabetic Chronic Kidney Disease
por: Zeng, Lingfeng, et al.
Publicado: (2023)

Relationship between Serial Serum Neutrophil-Lymphocyte Ratio, Cardiovascular Mortality, and All-Cause Mortality in Chinese Peritoneal Dialysis Patients
por: Lau, Lik Fung Sam, et al.
Publicado: (2023)

Obesity, Weight Gain, and Fluid Overload in Peritoneal Dialysis
por: Ng, Jack Kit-Chung, et al.
Publicado: (2022)

Recent advances in novel diagnostic testing for peritoneal dialysis-related peritonitis
por: Fung, Winston Wing-Shing, et al.
Publicado: (2022)

Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis
por: Ma, Terry King-Wing, et al.
Publicado: (2016)

Adipose and serum zinc alpha-2-glycoprotein (ZAG) expressions predict longitudinal change of adiposity, wasting and predict survival in dialysis patients
por: Chan, Gordon Chun-Kau, et al.
Publicado: (2022)

Adipose and Plasma microRNAs miR-221 and 222 Associate with Obesity, Insulin Resistance, and New Onset Diabetes after Peritoneal Dialysis
por: Chan, Gordon Chun Kau, et al.
Publicado: (2022)

Circulating Bacterial-Derived DNA Fragment Level Is a Strong Predictor of Cardiovascular Disease in Peritoneal Dialysis Patients
por: Szeto, Cheuk-Chun, et al.
Publicado: (2015)

Peritoneal dialysis after failed kidney allograft: Comparing patients with and without pd before transplant
por: Tian, Na, et al.
Publicado: (2023)

Urinary Long Non-Coding RNA Levels as Biomarkers of Lupus Nephritis
por: Szeto, Cheuk-Chun, et al.
Publicado: (2023)

The efficacy of managing fluid overload in chronic peritoneal dialysis patients by a structured nurse-led intervention protocol
por: Law, Man Ching, et al.
Publicado: (2019)

Peritoneal dialysis-related peritonitis caused by Pseudomonas species: Insight from a post-millennial case series
por: Lu, Wanhong, et al.
Publicado: (2018)

Metabolic syndrome in peritoneal dialysis patients
por: Li, Philip Kam-Tao, et al.
Publicado: (2008)

Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics
por: Peyro-Saint-Paul, Laure, et al.
Publicado: (2023)

Relation between MicroRNA Expression in Peritoneal Dialysis Effluent and Peritoneal Transport Characteristics
por: Chen, Jin, et al.
Publicado: (2012)

Metabolomic Changes of Human Proximal Tubular Cell Line in High Glucose Environment
por: Wei, Pascal Zhongping, et al.
Publicado: (2019)

Author Correction: Metabolomic Changes of Human Proximal Tubular Cell Line in High Glucose Environment
por: Wei, Pascal Zhongping, et al.
Publicado: (2020)

Kidney microRNA-21 Expression and Kidney Function in IgA Nephropathy
por: Szeto, Cheuk-Chun, et al.
Publicado: (2020)

Apixaban Dosing in Patients With Kidney Failure Treated With Peritoneal Dialysis
por: Lidgard, Benjamin, et al.
Publicado: (2023)

Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients
por: Ma, Terry King-Wing, et al.
Publicado: (2014)

Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis
por: Ng, Jack K.C., et al.
Publicado: (2023)

The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition – A Randomized Control Trial
por: Szeto, Cheuk-Chun, et al.
Publicado: (2015)

The effect of Dipeptidyl peptidase 4 (DPP-4) inhibitors on hemoglobin level in diabetic kidney disease: A retrospective cohort study
por: Zeng, Lingfeng, et al.
Publicado: (2023)

Stability and compatibility of antibiotics in peritoneal dialysis solutions
por: So, Simon Wai Yin, et al.
Publicado: (2022)

Establishing a Core Outcome Measure for Peritoneal Dialysis-related Peritonitis: A Standardized Outcomes in Nephrology—Peritoneal Dialysis Consensus Workshop Report
por: Shen, Jenny I., et al.
Publicado: (2022)

Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis
por: Falbo dos Reis, Pâmela, et al.
Publicado: (2021)

The use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism
por: Szeto, Cheuk-Chun, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dnuavn4v1ddfpba25nrkncibn2